China’s aggressive drive to replace brand-name foreign drugs with dirt-cheap homegrown generics has already taken a toll on global pharmaceutical companies’ local business. Now they’re almost nowhere ...
A case study on how a Pharmaceutical company specializing in cystic fibrosis treatments turned to DelveInsight for comprehensive analysis and insights into the digital cystic fibrosis landscape in the ...